Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection

In a study published in the latest issue of the journal Materials Today Advances, a team of researchers explored the utilities of graphene (GO) and its derivatives in combating the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlighting its applications in the biomedical domain.

Study: Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection. Image Credit: Rost9/ShutterstockStudy: Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection. Image Credit: Rost9/Shutterstock

GO has unique mechanical, electrical, and piezoelectric capabilities and exhibits antiviral properties due to the presence of several oxygen-containing functional groups, all of which make it an ideal choice for making products for containing or treating SARS-CoV-2 infections. Notably, not only GO nanoparticles, but GO-derivatives, such as reduced graphene oxide (r-GO), fullerene, graphene quantum dots (GQDs), carbon nanotubes (CNTs), etc. are quite useful against SARS-CoV-2.

There is an urgent need to develop diagnostic devices and treatment strategies to combat the SARS-CoV-2-induced pandemic. To this end, this research paper evaluates the utilities of GO and its derivatives in the fabrication of biosensors, personal protection equipment (PPE) kits, 3-D printing, and antiviral coatings, all of which may help to combat coronavirus disease 2019 (COVID-19).

Evaluating all possible biomedical applications of graphene

Given unique optical and electrochemical behavior, excellent electrocatalytic activities, and thermal, mechanical, and electrical properties of GO and its derivatives, they have been used to design effective biosensors to detect SARS-CoV-2 in patient blood and saliva samples. The authors highlighted a research work wherein a biosensing platform used graphene-oxide-glazed double interdigitated capacitive (DIDC) to detect the spike protein (S1) of SARS-CoV-2. This electroactive immune-sensing platform was rapid, highly sensitive, and showed a wide detection range. It exhibited selectivity against blood-borne antigens and could stand for almost ten days at 5°C. Therefore, this biochip could be potentially used as a portable, rapid point-of-care (POC) method for early diagnosis of SARS-CoV-2 using clinical samples.

The researchers also elaborately described a six-step process to synthesize a graphene-based PPE-kit with a high antimicrobial and antiviral efficiency. Further, they described the use of laser-induced graphene (LIG) technique in the fabrication of GO-coated self-sterilizing, re-usable face masks of the highest quality. In a study by Huang et al., the LIG-deposited face masks have shown 81.57% inhibition against the E. coli bacteria. Also, Guardian G-Volt face masks based on LIG techniques have effectively confined microbes by filtering out ~99% contaminants of more than 0.3 μm.

The researchers also described a graphene-based three-layered mask, ideal for people at high risk of viral exposure, such as healthcare and other frontline workers. In this mask, the graphene layer served as an antibacterial filter, the second polypropylene-based fabric layer hindered liquid and air particles, and the innermost layer of 100% cotton due to the highly hydrophilic nature of cotton, blocked viruses with high efficiency, compared to other fabrics.

Unfortunately, SARS-CoV-2 survives for a prolonged time on diverse surfaces, such as on plastic for over 72 h, on the tissue for approximately three hours, and seven days on a clinical mask. As GO/rGO-SO3 composites have shown inhibitory effects against a wide range of bacteria and viruses, including enveloped and non-enveloped viruses and DNA- and RNA-containing viruses, their use is highly recommended in hospitals, laboratories, operation theatres, incubators, ventilators, and public places,  to prevent the spread of SARS-CoV-2.

3D printing using composites of graphene-related materials (GRMs)-metal or GRMs-polymer as base materials having natural antiviral properties could also aid in making PPEs such as face masks, respirators, and face shields plus viral swabs, and ventilator parts.

Graphene’s cytotoxicity

The authors reviewed the cytotoxicity of GO and its derivatives and suggested that they are not as hazardous as other carbon materials, making them feasible as next-generation antivirals. Further, GO’s cytotoxicity was reduced when in close proximity to serum proteins, thus indicating that while it is poisonous to bacteria, it could be effective as a new-age antibiotic.

Other biomedical applications of graphene nanoparticles could be in bone fixation devices, scaffolds, and implants in orthopedics. However, clinical use would mandate more safety testing and research to confirm their biocompatibility with human tissues.

Conclusions 

The use of medical components and PPEs based on graphene-based materials is highly recommended as these products are lightweight, offer protection from UV rays, and have good antibacterial activity and thermal and electrical conductivity. Further, graphene-based coatings and surfaces could control the viral spread over high-contact segments because of their remarkable antibacterial activity.

To date, graphene-fabricated fabrics have not become suitable for large-scale manufacturing. However, studies examining the possibility of modifying graphene-based clothing could ensure its sustainability and comfort. 

In the future, researchers should find ways to resolve the limitations of graphene-based nanomaterials and modify their properties, making it possible for commercial manufacturing of GO-based products on a large scale. However, this should be done responsibly, factoring in the adverse outcomes of biomedical pollution such as open disposal of PPE kits, diagnosing kits, medical tools, and masks. 

Journal reference:
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2022, January 20). Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection. News-Medical. Retrieved on November 12, 2024 from https://www.news-medical.net/news/20220120/Prospective-of-graphene-and-graphene-based-derivatives-to-combat-SARS-CoV-2-infection.aspx.

  • MLA

    Mathur, Neha. "Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection". News-Medical. 12 November 2024. <https://www.news-medical.net/news/20220120/Prospective-of-graphene-and-graphene-based-derivatives-to-combat-SARS-CoV-2-infection.aspx>.

  • Chicago

    Mathur, Neha. "Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection". News-Medical. https://www.news-medical.net/news/20220120/Prospective-of-graphene-and-graphene-based-derivatives-to-combat-SARS-CoV-2-infection.aspx. (accessed November 12, 2024).

  • Harvard

    Mathur, Neha. 2022. Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection. News-Medical, viewed 12 November 2024, https://www.news-medical.net/news/20220120/Prospective-of-graphene-and-graphene-based-derivatives-to-combat-SARS-CoV-2-infection.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults